Fluorinex is a privately held medical device company founded in 2004 in collaboration with the New Generation Technology (NGT) Incubator in Nazareth, Israel. In 2007 Syneron Medical has invested in the company and enabled the increased efforts in R&D. The company operates and specializes in the tooth-care industry and leads the market with its innovative patented technology and devices: A teeth Fluorination device (Fluoritray®) for teeth decay prevention and reducing teeth sensitivity, and a teeth whitening device (UltraWyte®).
Using its innovative application of ‘Iontophoresis’ process, the company’s technology provides topical application of a much higher rate of Fluoride uptake than any existing commercial gel treatment presently in use. This significant breakthrough gives hope to over 90% of the world population that are suffering from the harassing tooth decay disease, and an immediate relief from teeth sensitivity that occurs after teeth whitening treatment, teeth cleaning procedure at the dentist clinic and gum retreat.
Based on the same technology, Fluorinex has developed its teeth whitening device that comes in a home-use and in-office professional versions. Tests results indicate that it attains close to a 100% brightness (per different shade degrees), in the shortest treatment duration in the market(!)